Day: October 3, 2024

What started as a hobby has unexpectedly turned into a thriving business for graphic designer Zainal Abas. Today, he is one of the few specialists restoring football jerseys, allowing fans to relive their cherished memories through his work. Working from home with an initial investment of around RM5,000 and starting as a part-time venture, Zainal, the owner of Prokit Services Enterprise, now earns an average monthly profit of RM4,000. During major tournament seasons like the World Cup, his earnings have soared to as much as RM10,000. The owner of Prokit Services Enterprise manages to make an average profit of RM4,000

KUALA LUMPUR, The FTSE Bursa Malaysia KLCI (FBM KLCI) futures were higher in early trade today. At 9.30 am, the October 2024 contract rose 4.5 points to 1,643.5, November 2024 improved 5.0 points to 1,647.5, December 2024 increased by 6.0 points to 1,651.0, and March 2025 gained 6.5 points to 1,639.5. Turnover stood at 1,259 lots, while open interest amounted to 43,388 contracts. The FBM KLCI, which opened higher, fell by 6.74 points to 1,632.57 after 30 minutes of trading. Source: BERNAMA News Agency

BUSAN, The National Film Development Corporation Malaysia (FINAS) will hold a meeting with film development agencies from ASEAN countries tomorrow, to discuss the desire to build a film community among the bloc. FINAS chief executive officer Datuk Azmir Saifuddin Mutallib said the discussion agenda included devising impactful programmes as well as discussing policies and incentives to help increase the film market among Southeast Asian countries. “We also want to explore in terms of, for example, organising a film festival that can help develop the market in the ASEAN region,” he told Bernama after attending the opening of the 29th Busan

KUALA LUMPUR, Bursa Malaysia staged a rebound from yesterday’s losses at the opening bell today, supported by renewed buying activities in selected heavyweights amid a recovery in the regional markets, according to an analyst. At 9.15 am, the FTSE Bursa Malaysia KLCI (FBM KLCI) jumped 4.40 points to 1,643.71 from Wednesday’s close of 1,639.31. The benchmark index had opened 1.39 points higher at 1,640.70. Market breadth was positive with advancers outpacing decliners 266 to 146, while 279 counters remained unchanged, 1,721 untraded, and nine suspended. Turnover stood at 204.34 million units valued at RM105.22 million. In a note today, Malacca

SALT LAKE CITY, Recursion (NASDAQ: RXRX), a leading clinical stage TechBio company decoding biology to industrialize drug discovery, today announced that the U.S. Food and Drug Administration (FDA) has cleared an investigational new drug (IND) application for a Phase 1/2 clinical trial of REC-1245, a new chemical entity for the treatment of biomarker-enriched solid tumors and lymphoma. Chris Gibson, Ph.D., Co-founder and CEO of Recursion said, ‘REC-1245 is a prime example of using an expansive AI-enabled platform for drug discovery. After exploring many predicted biological and chemical relationships across our maps of biology, we identified RMB39 as a novel target